APC-CY7-Labeled Monoclonal Anti-Human CD8 Antibody, Mouse IgG

产品评论
货号-规格
价格
Qty.
FABm003-05-50tests
¥1825.00
Fiber-add-1piece
可选服务
询价
合计0件 产品金额¥ 0

产品信息

应用(Application)

Flow Cytometry (Evaluation of the expression of CD8 on Human cells).

种属(Species)

Mouse

亚型(Isotype)

Mouse IgG

特异性(Specificity)

This product is a specific antibody specifically reacts with CD8 protein.

种属反应性(Reactivity)

Human

偶联(Conjugate)

APC-CY7

Excitation Wavelength: 637 nm

Emission Wavelength: 780 nm

推荐稀释比(Recommended Dilution)

1:20

制剂(Formulation)

Supplied as 0.2 μm filtered solution in PBS, 0.2% BSA, 0.03% Proclin 300, pH7.4 with trehalose as protectant.

Contact us for customized product form or formulation.

存储(Storage)

Please protect from light and avoid repeated freeze-thaw cycles.

This product is stable after storage at:

  1. Store at 2-8 °C for 12 months.

产品数据图

 

活性(Bioactivity)-FACS

CD8 FACS

Flow cytometric analysis of Human peripheral blood lymphocytes respectively staining with APC-CY7-Labeled Monoclonal Anti-Human CD8 Antibody Mouse IgG1 (Cat. No. FABm003-05) at 1:20 dilution (5 μL of the antibody stock solution corresponds to labeling of 2.5e5 cells in a final volume of 100 µL), compared with isotype control antibody. APC-CY7 signal was used to evaluate the binding activity (QC tested).

Protocol

 

产品评论
发表评论

背景

CD8a is a 32-34 kD type I glycoprotein. It forms a homodimer (CD8a/a) or heterodimer (CD8a/b) with CD8b. CD8, also known as T8 and Leu2, is a member of the immunoglobulin superfamily found on the majority of thymocytes, a subset of peripheral blood T cells, and NK cells (which express almost exclusively CD8a homodimers). CD8 acts as a co-receptor with MHC class I-restricted T cell receptors in antigen recognition and T cell activation and has been shown to play a role in thymic differentiation. Two domains in CD8a are important for function: the extracellular IgSF domain binds the α3 domain of MHC class I and the cytoplasmic CXCP motif binds the tyrosine kinase p56 Lck.

前沿进展

 
靶点信息
  • 英文全称:

    Cluster of differentiation 8

  • 中文全称:

    分化群8

  • 种类:

  • 上市药物数量:

    0 详情

  • 临床药物数量:

    11 详情

  • 最高研发阶段:

    临床三期

数据表和文档
联系我们
项目合作
查看更多项目
  • 产品SKU
  • 产品信息
  • 产品数据图
  • 产品评论
  • 背景